CellDx Tissue CellDx Tissue

Non-Invasive Test to Guide Cancer Treatment Decisions

Identifies Key Tumour Biomarkers From Blood
to Personalise Cancer Therapy

How does it work?

With just a simple blood draw, Pinaka™ isolates Circulating Tumour Cells (CTCs) and analyses important biomarkers. Using advanced and proven technology, Pinaka™ can detect CTCs in a wide range of cancer types, regardless of your age, gender, cancer stage, or treatment history. Because CTCs come directly from the tumour, their analysis provides information similar to traditional tumour tissue testing. Studies have shown that biomarker results from CTCs closely match those from tumour tissues, making Pinaka™ a reliable and effective tool for cancer care.

Click to view Trucheck™ Intelli FAQs.
Single Site Testing Single Site Testing

Key Benefits

  • Non-Invasive: Safe, convenient, and patient-friendly approach.
  • Reliable Alternative: Effective when tissue-based biomarker analysis is unavailable or inconclusive.
  • Accessible: No need for hospitalisation or visits to advanced healthcare facilities.
  • Risk-Free: Eliminates risks of pain, bleeding, and infection.
  • Versatile: Useful at any stage of your cancer care journey.
  • Effective for Early Detection: Suitable for tumours not visible in imaging.
  • Consistent Results: Not impacted by differences between tumours.
Got An Enquiry?
Contact Us.